Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Quelle est la performance du prix de l'action Virbac SA ?
Le prix actuel de Virbac SA est de $384.75, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Virbac SA ?
Virbac SA appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Virbac SA ?
La capitalisation boursière actuelle de Virbac SA est de $3.2B
Est-ce que Virbac SA est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 12 analystes ont établi des notations d'analystes pour Virbac SA, y compris 4 achat fort, 7 achat, 3 maintien, 0 vente et 4 vente forte